Profitability
Weight: 25%
B-
64
- 5yr Avg ROIC 8.5%
- Operating Margin Trend +1.36 pp/yr
AMPH
Amphastar Pharmaceuticals, Inc.
AlphaQuality composite grade, weighted for platform & compounding fcf businesses.
Capital Efficiency
Weight: 15%
B+
77
- 5yr Avg ROE 13.9%
- 5yr Share-Count CAGR -0.8%
Growth Quality
Weight: 25%
A-
85
- 5yr Revenue CAGR 13.2%
- 5yr EPS CAGR 12.9%
- Revenue-Growth Years (5) 4/5
Cash Generation
Weight: 20%
A
93
- 5yr FCF Margin 18.4%
- 5yr FCF/NI Conversion 1.04x
Balance Sheet
Weight: 10%
C+
59
- Net Debt / EBITDA 2.50x
- Interest Coverage (EBIT/Int) 5.85x
- Altman Z-Score 2.16
Stability
Weight: 5%
D+
43
- EPS Volatility (σ/μ) 0.83
- Piotroski F-Score 6
- Negative-Revenue Years (5) 1/5
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.1 of 2 gurus held; 1 added; 1 full exit.
- Holders
- 1 -1
- Avg Δ position
- +19.5%
- New buys
- 0
- Full exits
- 1
- Greenblatt sold -100%
- Cooperman increased +19%